4531
YUKI GOSEI KOGYO CO.,LTD.
有機合成薬品工業株式会社Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. The company was incorporated in 1947 and is headquartered in Tokyo, Japan.
Price
¥356
Market Cap
¥7.8B
Ent. Value
¥15.0B
Net Debt
−¥7.2B
Shares Out.
22.0M
P / E
8.6×
EV / EBIT
12.3×
⚠ TSE Capital Mandate
P / Book
0.59×
P / NCAV
N/M
Div. Yield
2.53%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥15.1B | ¥12.9B | ¥12.8B | ¥12.4B |
| Cost of Sales | ¥11.8B | ¥9.7B | ¥9.8B | ¥10.0B |
| Gross Profit | ¥3.3B | ¥3.3B | ¥3.0B | ¥2.4B |
| SG&A | ¥2.1B | ¥2.1B | ¥2.2B | ¥1.9B |
| Operating Income | ¥1.2B | ¥1.1B | ¥897M | ¥413M |
| Non-Operating Income | ¥66M | ¥74M | ¥81M | ¥80M |
| Dividend Income | ¥45M | ¥41M | ¥39M | ¥34M |
| Interest Income | ¥0M | ¥0M | ¥0M | ¥0M |
| Non-Operating Expenses | ¥143M | ¥69M | ¥317M | ¥96M |
| Interest Expense | ¥75M | ¥49M | ¥50M | ¥50M |
| Ordinary Income | ¥1.1B | ¥1.1B | ¥660M | ¥397M |
| Pre-tax Income | ¥1.1B | ¥905M | ¥641M | ¥289M |
| Income Taxes | ¥228M | ¥129M | ¥84M | ¥41M |
| Current Tax | ¥156M | ¥137M | ¥94M | ¥40M |
| Deferred Tax | ¥37M | ¥-8M | ¥-9M | ¥1M |
| Net Income (owners) | ¥896M | ¥776M | ¥556M | ¥248M |
| EBITDA | ¥2.2B | ¥2.1B | ¥1.8B | ¥1.3B |
| EPS | ¥41.40 | ¥35.57 | ¥25.51 | ¥11.37 |
| Shares Outstanding | 22.0M | 22.0M | 22.0M | 22.0M |
| Shares Issued (total) | 22.0M | 22.0M | 22.0M | 22.0M |